International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer


Recommended Conferences for Antiretrovirals


As per available reports about 06 through its relevant journals, 16 Conferences, 02 workshops are presently dedicated exclusively to Antiretrovirals and about 93 articles are being published on Antiretrovirals.

Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics for bacteria, specific antivirals are used for specific viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development. Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and ant parasitic drugs, or antiviral drugs based on monoclonal antibodies. Most antivirals are considered relatively harmless to the host, and therefore can be used to treat infections. They should be distinguished from viricides, which are not medication but deactivate or destroy virus particles, either inside or outside the body.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance :
The general idea behind modern antiviral drug design is to identify viral proteins, or parts of proteins, that can be disabled. These "targets" should generally be as unlike any proteins or parts of proteins in humans as possible, to reduce the likelihood of side effects. The targets should also be common across many strains of a virus, or even among different species of virus in the same family, so a single drug will have broad effectiveness. The target proteins can be manufactured in the lab for testing with candidate treatments by inserting the gene that synthesizes the target protein into bacteria or other kinds of cells. The cells are then cultured for mass production of the protein, which can then be exposed to various treatment candidates and evaluated with "rapid screening" technologies.
The treatment of HIV/AIDS normally includes the use of multiple antiretroviral drugs in an attempt to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy (HAART). HAART decreases the patient's total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death. HIV treatment has been proven so successful that in many parts of the world HIV has become a chronic condition in which progression to AIDS has become increasingly rare. Anthony Fauci, head of the US National Institute of Allergy and Infectious Diseases has written "With collective and resolute action now and a steadfast commitment for years to come, an AIDS-free generation is indeed within reach." In the same paper he notes that an estimated 700,000 lives were saved in 2010 alone due to antiretroviral therapy. As another commentary in The Lancet noted, "Rather than dealing with acute and potentially life-threatening complications, clinicians are now confronted with managing a chronic disease that in the absence of a cure will persist for many decades"
The US Department of Health and Human Services and other organizations recommend offering antiretroviral treatment to all patients with HIV. Because of the complexity of selecting and following a regimen, the potential for side-effects, and the importance of taking medications regularly to prevent viral resistance, such organizations emphasize the importance of involving patients in therapy choices and recommend analyzing the risks and the potential benefits.

Market Analysis:

As of 2014 it is the 10th most populous city in Africa and home to 64% of the Western Cape's population. Recent data on HIV diagnosis make it clear that HIV touches every corner of United States. According to these data, by region, the number of people diagnosed with HIV and the of HIV diagnoses (number of diagnoses per 100,000 people) is highest in the South (24,323 diagnoses or 20.5 per 100,000 people). Next highest is the Northeast (8,908; 15.9), followed by the West (8,013; 10.8) and the Midwest (6,109; 9.0). From 2009 to 2013, the rate of HIV diagnoses in the West decreased, and the rates in the Northeast, Midwest, and South remained stable.

International symposium and workshops:

  • 8TH IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, Bangkok 2015
  • Palm Springs Symposium on HIV/AIDS, March 3-5, 2016 Palm Springs, California
  • 22nd International Symposium on Hepatitis C Virus and Related Viruses - October 9-13, 2015
  • 10th International Workshop on HIV Transmission - Principles of Intervention, to be held in Atlanta, GA, USA on December 5-6, 2015
  • International Symposium on HIV Medicine 2016

List of Best International Conferences :

Relevant Society and Associations:

  • International Association of Providers of AIDS Care (IAPAC).London
  • International Antiviral Society–USA
  • International AIDS Society, USA
  • British HIV Association
  • International Association of Providers of AIDS Care (IAPAC).London
  • International Antiviral Society–USA
  • International AIDS Society, USA
  • International Society for Antiviral Research.
  • International Antivirals and Vaccines Society.
  • International Society for Influenza and Other Respiratory Virus Disease.
  • Society for Clinical Trials (SCT)
  • Stanford Genomic Resources
  • The United States Pharmacopeia (USP)
  • National Science Foundation (NSF)
  • Federal Laboratory Consortium for Technology Transfer
  • The Society for Medicines Research
  • Royal Society of Chemistry
  • Alzheimer's Drug Discovery Foundation
  • American Association of Pharmaceutical Scientists

Companies :

  • GlaxoSmithKline (GSK), USA
  • Merck, USA
  • Cipla, India
  • Ranbaxy, India
  • Hetero, India
  • Big Pharma
  • Gilead Sciences, USA
  • Bristol Myers-Squibb , USA
  • Tibotec Therapeutics, USA
  • Pfizer, USA
  • Abbott Laboratories, USA
  • Johnson & Johnson
  • Novartis
  • Roche
  • Sanofi
  • Bayer HealthCare
  • AstraZeneca
  • Eli Lilly
  • Cell Biologyare Lancaster Laboratories
  • Millennium Pharmaceuticals Inc
  • PrioBio
  • Array BioPharma
  • Origene
  • Alexion Pharmaceuticals
  • ImmunoGen Inc

List of Journals

  • Journal of AIDS & Clinical Research
  • Journal of Clinical & Cellular Immunology
  • Journal of Antivirals & Antiretrovirals
  • Journal of Neurological Disorders
  • Journal of Clinical & Experimental Pathology

This page will be updated regularly.

This page was last updated on February 7, 2023

Conference Series Destinations